Clinical Trials for BMT and Cellular Immunotherapy Program
Moffitt Cancer Center’s ambitious approach to research and facilitating breakthroughs in cancer treatment is one of the many reasons why referring physicians trust us with their patients’ care. Research is a vital part of our Blood and Marrow Transplant (BMT) and Cellular Immunotherapy Program, where our multispecialty team is continually exploring progressive treatment options through innovative clinical trials.
Moffitt patients who are eligible to participate in a clinical trial benefit from some of the latest advancements in treatment before they are made available elsewhere. Our BMT and Cellular Immunotherapy Program clinical trials focus extensively on stem cell transplantation, as well as developments in immunotherapies and novel chemotherapy combinations for patients with a wide array of hematological conditions and certain solid tumors.
Our commitment to improving patient outcomes
Moffitt is a nationally recognized leader in hematological cancer research. Our program is among the largest and most active in the Southeast, and is a core member of the BMT Clinical Trials Network. Moffitt is also the only Florida-based practice to be recognized as a Comprehensive Cancer Center by the National Cancer Institute—a distinction that highlights our unrelenting commitment to improving cancer treatment options and enhancing quality of life for the patients we serve.
Refer a patient
To refer a patient to Moffitt, complete our online form or contact a physician liaison for timely assistance. Our team works hard to respond to all referral requests within 48 hours. While your patient is receiving care at Moffitt, we will continually provide you with detailed updates on his or her progress and will promptly address any questions you may have.
If you would like to receive more detailed information about what clinical trials are currently available in Moffitt’s BMT and Cellular Immunotherapy Program, call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.